NCT00005580View on ClinicalTrials.gov

Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

LeukemiaLymphoma

Interventions

DRUG

bryostatin 1

DRUG

fludarabine phosphate

Trial Locations (3)

10021

New York Presbyterian Hospital - Cornell Campus, New York

19111

Fox Chase Cancer Center, Philadelphia

23298-0037

Massey Cancer Center, Richmond

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Virginia Commonwealth University

OTHER

NCT00005580 - Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter